VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new-generation medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, has been granted a…
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, was featured in a research report by the Benchmark Company…
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative solutions for the worldwide life science and other industries, recently reported its third-quarter financial results and provided a business update, which included initial expectations for 2021…
SRAX to host 13th Annual LD Micro Main Event on December 14-15, 2020 via its SRAX Virtual Events SaaS platform Conference will feature over 250 company presentations, interviews include Shaquille O’Neal and 2020 presidential candidate…
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today sent a letter to shareholders regarding its virtual special meeting of stockholders, originally scheduled for…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, recently appeared on Gamechangers LIVE, a podcast series that…
Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading producer of uranium in the United States, recently announced a corporate update and financial results for the quarter ended Sept. 30, 2020 (https://ibn.fm/CEDLQ). In addition to…
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced the launch of Trxade Prime, a revolutionary service offered by the company’s Integra Pharma Solutions subsidiary. According to the update,…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, is advancing a drug candidate it hopes will beat…
Predictive Oncology (NASDAQ: POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery. Through its subsidiary Soluble Biotech, the company delivers a solution that…
Creatd (NASDAQ: CRTD), the parent company of Vocal, a proprietary creator platform, today announced that it has converted its 10,000th freemium creator to a paid Vocal+ subscriber, a milestone achieved several weeks ahead of management’s…
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, has reached a significant milestone. The company successfully completed the technology transfer of its manufacturing process for…
The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that its president and CEO, Richard Wright, is scheduled to present in…
NETE results include year-over-year increases in revenue and transaction volume 45% of NETE clients in restaurant business, management expects rebound once states reopen NETE plans to divest payments processing model to enter EV industry through…
Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), recently announced that another casino in Southern California signed an agreement with Knightscope to add a K5 ASR to its staff.…
COVID-19, the election, and preference shift towards growth-oriented stocks causing unprecedented stock market volatility SRAX’s Sequire SaaS platform unlocks big data investor insights for public companies Sequire’s user base grown to over one million investors,…
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights to publicly traded companies through Sequire, today announced that Shaquille O’Neal and Brock Pierce will be the keynote speakers at the 13th Annual…
Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that the European Commission, through the Horizon 2020 framework program, has awarded a funding grant of nearly 20 million Euro…
180 Life Sciences (NASDAQ: ATNF, ATNFW), a clinical-stage biotechnology company with its lead indication in phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today…
WTER set to expand across the entire spectrum of hospitality, foodservice markets through key partnerships with Dot Foods, IBA Lucrative segments such as golf foodservice, fast casuals, and vending and micro markets rapidly growing amid…
Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it will present at the Benzinga Global Small Cap Conference taking place virtually on Dec. 8-9, 2020. Genprex’s…
Energy Fuels has produced rare earth element (“REE”) concentrate on a pilot scale at wholly owned White Mesa Mill. The high-purity concentrate is ready to send to separation plant for final acceptance test work. Company…
Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced that it will participate in a fireside chat hosted by IPO Edge in partnership with The Palm Beach Hedge…
The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced an expanded partnership with KeHE, which now includes the A88CBD(TM) topical products,…
Net Element (NASDAQ: NETE) is transforming its business model to enter the electric vehicle (“EV”) industry through a reverse-merger with California-based Mullen Technologies Inc. The strategic move positions the company to benefit amid the dropping…
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative solutions for the worldwide life science and other industries, recently secured its first U.S. patent for its innovative Ultra Shear Technology (“UST”) platform. Utilizing ultra-high pressure…
SRAX’s Sequire, an investor intelligence platform, seeks to combine investor intelligence services with detailed shareholder insights Sequire boasts 91 publicly listed subscribers on its platform along with over 1 million investors and traders Sequire’s platform…
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that its virtual Special Meeting of Stockholders, which was scheduled for Dec. 1, 2020, was…
Tesla recently illustrated the enthusiasm surrounding the EV sector by becoming the newest entrant to the S&P500 equity index Investor interest in the sector has spilled over to Net Element, with one the world’s largest…
Biotechnology developer CNS Pharmaceuticals is preparing, with its partner WPD Pharmaceuticals, a global set of Phase 2 trials for its drug candidate Berubicin, which has shown promise in combating the effectively fatal glioblastoma multiforme (“GBM”)…
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights to publicly traded companies through Sequire, today announced that it will host the 13th Annual LD Micro Main Event, a prominent two-day virtual…
Blue Hat Interactive (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, has signed a definitive agreement for the acquisition of 51% of Fuzhou…
WrapTechnologies (NASDAQ:WRAP), an innovator of modern policing solutions, announced that BolaWrap(R), its patented, hand-held remote restraint device, was used by the Virginia Police Department in Minnesota earlier this month. The successful deployment of the revolutionary…
Financial report notes working capital of $44.7 million at end of Q3 2020, increase of 17% over Q2 2020 Key quarter highlights include becoming debt-free, progress on rare earth elements (“REEs”) CEO reports company making “significant strides…
Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, on Monday announced its commencement of clinical trial site recruitment for its upcoming Acclaim-1 clinical trial for the treatment of non-small…
VistaGen Therapeutics (NASDAQ: VTGN) has appointed a new vice president of translational medicine. A pioneer in the development of neuroactive steroids known as pherines, Louis Monti, MD., PhD., developed the original scientific platform that enabled…
VTGN CEO “even more excited about PH94B’s potential to change lives without the risky side effects and safety concerns of benzos” Study results suggest PH94B’s mechanism of action may not have benzodiazepine-like side effects, such…
NETE plans to divest payments processing model to enter EV industry through proposed merger with privately-held Mullen Technologies Inc. Merger allows Mullen stakeholders to obtain majority of stock while accelerating process of taking company public,…
Jupiter Wellness (NASDAQ: JUPW), a leading developer of cannabidiol (“CBD”) based therapeutics and wellness products, today announced that it was featured in a new video interview with SNN Network, “The Official Small-, Micro- and Nano-Cap…
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that the first two patients have been dosed in Turkey for its Phase 2 trial. The trial…